Lynx1 Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-137,923	Closed	-$1.93M	–	19
2024 Q1	$1.93M	Buy	137,923 +9,310	+7%	+$130K	0.5%	13
2023 Q4	$1.09M	Buy	128,613 +10,825	+9%	+$91.7K	0.43%	14
2023 Q3	$1.05M	Buy	+117,788	New	+$1.05M	0.7%	15